Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 306

1.

Persistent cerebrovascular effects of MDMA and acute responses to the drug.

Ferrington L, Kirilly E, McBean DE, Olverman HJ, Bagdy G, Kelly PA.

Eur J Neurosci. 2006 Jul;24(2):509-19. Epub 2006 Jul 12.

PMID:
16836637
[PubMed - indexed for MEDLINE]
2.

Acute tryptophan depletion potentiates 3,4-methylenedioxymethamphetamine-induced cerebrovascular hyperperfusion in adult male Wistar rats.

van Donkelaar EL, Kelly PA, Dawson N, Blokland A, Prickaerts J, Steinbusch HW, Ferrington L.

J Neurosci Res. 2010 May 15;88(7):1557-68. doi: 10.1002/jnr.22308.

PMID:
19998482
[PubMed - indexed for MEDLINE]
3.

Acute methylenedioxymethamphetamine administration: effects on local cerebral blood flow and glucose utilisation in the Dark Agouti rat.

Quate L, McBean DE, Ritchie IM, Olverman HJ, Kelly PA.

Psychopharmacology (Berl). 2004 May;173(3-4):287-95. Epub 2004 Feb 20.

PMID:
14985928
[PubMed - indexed for MEDLINE]
4.

Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of L-5-hydroxytryptophan.

Wang X, Baumann MH, Dersch CM, Rothman RB.

Neuroscience. 2007 Aug 10;148(1):212-20. Epub 2007 Jul 12.

PMID:
17629409
[PubMed - indexed for MEDLINE]
5.

Acute and long-term effects of a single dose of MDMA on aggression in Dark Agouti rats.

Kirilly E, Benko A, Ferrington L, Ando RD, Kelly PA, Bagdy G.

Int J Neuropsychopharmacol. 2006 Feb;9(1):63-76. Epub 2005 Aug 1.

PMID:
16060968
[PubMed - indexed for MEDLINE]
6.

Partial lesion of the serotonergic system by a single dose of MDMA results in behavioural disinhibition and enhances acute MDMA-induced social behaviour on the social interaction test.

Ando RD, Benko A, Ferrington L, Kirilly E, Kelly PA, Bagdy G.

Neuropharmacology. 2006 Jun;50(7):884-96. Epub 2006 Feb 9.

PMID:
16472832
[PubMed - indexed for MEDLINE]
7.

Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT 2C receptor responsivity.

Bull EJ, Hutson PH, Fone KC.

Neuropharmacology. 2003 Mar;44(4):439-48.

PMID:
12646281
[PubMed - indexed for MEDLINE]
8.

Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA.

Balogh B, Molnar E, Jakus R, Quate L, Olverman HJ, Kelly PA, Kantor S, Bagdy G.

Psychopharmacology (Berl). 2004 May;173(3-4):296-309. Epub 2004 Apr 9.

PMID:
15083265
[PubMed - indexed for MEDLINE]
9.

Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats.

Durkin S, Prendergast A, Harkin A.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1894-901. doi: 10.1016/j.pnpbp.2008.09.008. Epub 2008 Sep 13.

PMID:
18824064
[PubMed - indexed for MEDLINE]
10.

In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function.

Callaghan PD, Owens WA, Javors MA, Sanchez TA, Jones DJ, Irvine RJ, Daws LC.

J Neurochem. 2007 Feb;100(3):617-27. Epub 2006 Dec 1.

PMID:
17181558
[PubMed - indexed for MEDLINE]
11.

Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine.

Callaghan PD, Farrand K, Salem A, Hughes P, Daws LC, Irvine RJ.

Eur J Pharmacol. 2006 Sep 28;546(1-3):74-81. Epub 2006 Jul 25.

PMID:
16925993
[PubMed - indexed for MEDLINE]
12.
13.

Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat.

O'Loinsigh ED, Boland G, Kelly JP, O'Boyle KM.

Prog Neuropsychopharmacol Biol Psychiatry. 2001 Apr;25(3):621-38.

PMID:
11371001
[PubMed - indexed for MEDLINE]
14.

MDMA-evoked changes in cerebral blood flow in living porcine brain: correlation with hyperthermia.

Rosa-Neto P, Olsen AK, Gjedde A, Watanabe H, Cumming P.

Synapse. 2004 Sep 15;53(4):214-21.

PMID:
15266553
[PubMed - indexed for MEDLINE]
15.
16.

Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain.

Bull EJ, Porkess V, Rigby M, Hutson PH, Fone KC.

J Psychopharmacol. 2006 Mar;20(2):272-80.

PMID:
16510485
[PubMed - indexed for MEDLINE]
18.

Acute SSRI-induced anxiogenic and brain metabolic effects are attenuated 6 months after initial MDMA-induced depletion.

Andó RD, Adori C, Kirilly E, Molnár E, Kovács GG, Ferrington L, Kelly PA, Bagdy G.

Behav Brain Res. 2010 Mar 5;207(2):280-9. doi: 10.1016/j.bbr.2009.10.011. Epub 2009 Oct 17.

PMID:
19840819
[PubMed - indexed for MEDLINE]
19.

Elevated BDNF protein level in cortex but not in hippocampus of MDMA-treated Dark Agouti rats: a potential link to the long-term recovery of serotonergic axons.

Adori C, Andó RD, Ferrington L, Szekeres M, Vas S, Kelly PA, Hunyady L, Bagdy G.

Neurosci Lett. 2010 Jul 5;478(2):56-60. doi: 10.1016/j.neulet.2010.04.061. Epub 2010 May 8.

PMID:
20435092
[PubMed - indexed for MEDLINE]
20.

Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study.

Chang L, Grob CS, Ernst T, Itti L, Mishkin FS, Jose-Melchor R, Poland RE.

Psychiatry Res. 2000 Feb 28;98(1):15-28.

PMID:
10708923
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk